secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001396814-23-000029
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira stockholders approve 3.3M share increase in equity plan; director Gary Pace faces significant withhold vote
--------------------------------------------------------------------------------

- Stockholders approved Amended 2011 Stock Incentive Plan, adding 3,300,000 new shares for future grants.
- Gary Pace elected as Class III director with 16.1M for vs 23.9M withhold (40.3% support).
- KPMG ratified as auditor for FY2023 with 41.9M votes for (99.3% of votes cast).
- Advisory 'say-on-pay' vote approved with 34.6M for (86.5% of votes cast).
- Plan approval vote: 24.1M for, 15.8M against (60.4% for, excluding broker non-votes).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681423000029/0001396814-23-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681423000029/pcrx-20230613.htm
  HTML page:      https://secwatch.observer/filing/0001396814-23-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer